Supports translational research projects aimed at developing assays, screening methods, and initial characterization of potential analgesic agents including small molecules, biologics, and natural products. The goal is to advance these projects to meet criteria for the Pain Therapeutics Development Program, focusing on safe, effective, and non-addictive pain treatments. Clinical trials are not allowed under this funding.
Eligible applicants include a wide range of U.S. organizations such as tribal governments, educational institutions, nonprofits, small businesses, and government entities. Specific eligibility details should be confirmed with the funding organization.
